Würstle, Silvia
Lee, Alina
Kortright, Kaitlyn E.
Winzig, Franziska
An, William
Stanley, Gail L.
Rajagopalan, Govindarajan
Harris, Zach
Sun, Ying
Hu, Buqu
Blazanin, Michael
Hajfathalian, Maryam
Bollyky, Paul L.
Turner, Paul E. http://orcid.org/0000-0003-3490-7498
Koff, Jonathan L.
Chan, Benjamin K.
Article History
Received: 25 September 2023
Accepted: 15 January 2024
First Online: 1 February 2024
Competing interests
: All authors declare that they have no competing interests perceived as unduly influencing the findings of this research project. PET is cofounder of Felix Biotechnology, Inc., a company that seeks to develop phages for human therapy. Yale University has an institutional conflict of interest related to this project. Yale may receive financial benefit related to the therapy used in this protocol.